跳至主要内容
临床试验/RPCEC00000377
RPCEC00000377尚未招募4 期

Effects of policosanol on blood pressure values and lipid profile in patients with pre-hypertension or with grade I hypertension. - PoliHTA-01

ational Center for Scientific Research0 个研究点开始时间: 2021年6月30日最近更新:
适应症

试验速览

阶段
4 期
状态
尚未招募
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomized controlled trial. Masking: Double Blind. Control group: Placebo. Assignment: Parallel. Purpose: Treatment

入排标准

年龄范围
30 years 至 59 years(—)
性别
All

入选标准

  • 1) Patients with pre-hypertension (SBP: 120-139, DBP: 80-89 mmHg),
  • 2) Patients with grade I hypertension (SBP: 140-159, DBP: 90-99 mmHg),
  • 3) With one or two cardiovascular risk factors,
  • 4) Without previous antihypertensive treatment,
  • 5) Of both sexes,
  • 6) Aged between 30 and 59 years,
  • 7) Without a history of diagnosed vascular diseases,
  • 8) Who agreed to participate in the study, signing your informed consent.

排除标准

  • Patients with:
  • 1) Grade II hypertension (SBP: 160-179, DBP: 100-109 mmHg)
  • 2) Grade III hypertension (SBP: 180 and more, DBP: 110 mmHg and more).
  • 3) Isolated systolic hypertension (SBP: 140 and more, DBP less than 90 mmHg).
  • 4) Vascular diseases (coronary, cerebrovascular, peripheral) diagnosed.
  • 5) Diagnosed neoplasms.
  • 6) Diseases or use of medications that could affect blood pressure: endocrinopathies, use of glucorticoids, malabsorption, psychotropic drugs, etc.
  • 7) Any other special condition that at the discretion of the doctor puts your health and life at risk during the study.

研究者

发起方
ational Center for Scientific Research

相似试验

Policosanol in patients with pre-hypertension or... | 临床试验